Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome.

Publication Year: 2023

DOI:
10.1161/STROKEAHA.122.041690

PMCID:
PMC10121246

PMID:
37035916

Journal Information

Full Title: Stroke

Abbreviation: Stroke

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr Wermer reports independent support from the Netherlands Organization for Scientific Research (NWO VIDI grant 9171337), the Dutch Research Council (NWO memorable BIONIC [Biomarkers for Cognitive Impairment due to Cerebral Amyloid Angiopathy] 733050822), the Dutch Heart Foundation (Clinical Established Investigator grant 2016T86), the Dutch Brain Foundation and the Dutch cerebral amyloid angiopathy (CAA) foundation. Dr Terwindt reports independent support from the Dutch Research Council (Nederlandse Organisatie voor Wetenschappelijk Onderzoek memorable BIONIC 733050822), the Dutch Heart Foundation, the Dutch Brain Foundation and the Dutch CAA foundation. Dr Schreuder reports independent support from the Dutch Heart Foundation (Senior Clinical Scientist grant 2019T060), the Dutch Heart Foundation and the Swedisch Orphan Biovitrum AB. Dr Klijn reports disclosures all unrelated to this study: support from the Netherlands Cardiovascular Research Initiative, which is supported by the Dutch Heart Foundation, CVON2015-01: CONTRAST (Collaboration for New Treatments of Acute Stroke), and the support of the Brain Foundation Netherlands (HA2015.01.06). The collaboration project is additionally financed by the Ministry of Economic Affairs by means of the public-private partnerships allowance made available by the Top Sector Life Sciences & Health to stimulate public-private partnerships (LSHM17016). This work was funded in part through unrestricted funding by Stryker, Medtronic, and Cerenovus; the funding sources were not involved in study design, monitoring, data collection, statistical analyses, interpretation of results, or article writing. Radboud University Medical Center and Erasmus MC received additional unrestricted funding on behalf of CONTRAST, for the execution of the Dutch Intracerebral Hemorrhage (ICH) Surgery Trial pilot study from Penumbra Inc. For the Dutch ICH Surgery Trial, they also received a grant from ZonMw/Promising care (grant 80- 86200-08-25001). The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025